<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://new.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Fri, 07 Aug 2026 17:00:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://new.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  SCHEDULE 13G  Optimi Health Corp.                    Filed by: Stevens Dane Nicholas</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Optimi+Health+Corp.++++++++++++++++++++Filed+by%3A+Stevens+Dane+Nicholas/26892014.html</link>
   <description>si-local-file:///var/storage/secattach/20260807/26892014.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Optimi+Health+Corp.++++++++++++++++++++Filed+by%3A+Stevens+Dane+Nicholas/26892014.html</guid>
   <pubDate>Fri, 07 Aug 2026 17:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.53098441</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPTH</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G  Optimi Health Corp.                    Filed by: Stevens Dane Nicholas</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Optimi+Health+Corp.++++++++++++++++++++Filed+by%3A+Stevens+Dane+Nicholas/26892014.html</link>
   <description>si-local-file:///var/storage/secattach/20260807/26892014.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Optimi+Health+Corp.++++++++++++++++++++Filed+by%3A+Stevens+Dane+Nicholas/26892014.html</guid>
   <pubDate>Fri, 07 Aug 2026 17:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.53098441</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPTH</category>
   	  </item>
  <item>
   <title>Form  6-K        Optimi Health Corp.       For: Aug 07</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Optimi+Health+Corp.+++++++For%3A+Aug+07/26889042.html</link>
   <description>si-local-file:///var/storage/secattach/20260807/26889042.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Optimi+Health+Corp.+++++++For%3A+Aug+07/26889042.html</guid>
   <pubDate>Fri, 07 Aug 2026 10:36:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.53098441</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPTH</category>
   	  </item>
  <item>
   <title>Form  6-K        Optimi Health Corp.       For: Aug 07</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Optimi+Health+Corp.+++++++For%3A+Aug+07/26889042.html</link>
   <description>si-local-file:///var/storage/secattach/20260807/26889042.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Optimi+Health+Corp.+++++++For%3A+Aug+07/26889042.html</guid>
   <pubDate>Fri, 07 Aug 2026 10:36:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.53098441</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPTH</category>
   	  </item>
  <item>
   <title>Form  6-K        Optimi Health Corp.       For: Jul 28</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Optimi+Health+Corp.+++++++For%3A+Jul+28/26828452.html</link>
   <description>si-local-file:///var/storage/secattach/20260728/26828452.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Optimi+Health+Corp.+++++++For%3A+Jul+28/26828452.html</guid>
   <pubDate>Tue, 28 Jul 2026 17:29:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.53098441</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPTH</category>
   	  </item>
  <item>
   <title>Form  6-K        Optimi Health Corp.       For: Jul 28</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Optimi+Health+Corp.+++++++For%3A+Jul+28/26828452.html</link>
   <description>si-local-file:///var/storage/secattach/20260728/26828452.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Optimi+Health+Corp.+++++++For%3A+Jul+28/26828452.html</guid>
   <pubDate>Tue, 28 Jul 2026 17:29:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.53098441</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPTH</category>
   	  </item>
  <item>
   <title>Form  6-K        Optimi Health Corp.       For: Jul 20</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Optimi+Health+Corp.+++++++For%3A+Jul+20/26787805.html</link>
   <description>si-local-file:///var/storage/secattach/20260720/26787805.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Optimi+Health+Corp.+++++++For%3A+Jul+20/26787805.html</guid>
   <pubDate>Mon, 20 Jul 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.53098441</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPTH</category>
   	  </item>
  <item>
   <title>Form  6-K        Optimi Health Corp.       For: Jul 20</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Optimi+Health+Corp.+++++++For%3A+Jul+20/26787805.html</link>
   <description>si-local-file:///var/storage/secattach/20260720/26787805.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Optimi+Health+Corp.+++++++For%3A+Jul+20/26787805.html</guid>
   <pubDate>Mon, 20 Jul 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.53098441</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPTH</category>
   	  </item>
  <item>
   <title>Form  S-8        Optimi Health Corp.                  </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Optimi+Health+Corp.++++++++++++++++++/26741811.html</link>
   <description>si-local-file:///var/storage/secattach/20260707/26741811.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Optimi+Health+Corp.++++++++++++++++++/26741811.html</guid>
   <pubDate>Tue, 07 Jul 2026 16:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.53098441</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPTH</category>
   	  </item>
  <item>
   <title>Form  S-8        Optimi Health Corp.                  </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Optimi+Health+Corp.++++++++++++++++++/26741811.html</link>
   <description>si-local-file:///var/storage/secattach/20260707/26741811.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Optimi+Health+Corp.++++++++++++++++++/26741811.html</guid>
   <pubDate>Tue, 07 Jul 2026 16:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.53098441</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPTH</category>
   	  </item>
  <item>
   <title>Optimi Health ships psilocybin capsules to Australia in third export</title>
   <link>http://www.streetinsider.com/Corporate+News/Optimi+Health+ships+psilocybin+capsules+to+Australia+in+third+export/26704240.html</link>
   <description>&lt;p&gt;Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN0) has completed its third commercial shipment of 5mg psilocybin capsules to Australia since launching the product in September 2025, according to a company press release.&lt;/p&gt;&lt;p&gt;The shipment consisted of 1,000 capsules produced at Optimi's GMP-certified facility in Princeton, British Columbia, and exported under authorization from Health Canada. The capsules are prescribed in Australia for treatment-resistant depression, defined as major depression that has not responded to multiple standard antidepressant treatments.&lt;/p&gt;&lt;p&gt;In Australia, the capsules are dispensed under the Therapeutic Goods Administration's Authorized Prescriber Scheme and are reimbursed by payers including the Department of Veterans'</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Optimi+Health+ships+psilocybin+capsules+to+Australia+in+third+export/26704240.html</guid>
   <pubDate>Mon, 29 Jun 2026 11:37:53 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">8BN0</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPTH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPTI</category>
   	  </item>
  <item>
   <title>Optimi Health ships psilocybin capsules to Australia in third export</title>
   <link>http://www.streetinsider.com/Corporate+News/Optimi+Health+ships+psilocybin+capsules+to+Australia+in+third+export/26704240.html</link>
   <description>&lt;p&gt;Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN0) has completed its third commercial shipment of 5mg psilocybin capsules to Australia since launching the product in September 2025, according to a company press release.&lt;/p&gt;&lt;p&gt;The shipment consisted of 1,000 capsules produced at Optimi's GMP-certified facility in Princeton, British Columbia, and exported under authorization from Health Canada. The capsules are prescribed in Australia for treatment-resistant depression, defined as major depression that has not responded to multiple standard antidepressant treatments.&lt;/p&gt;&lt;p&gt;In Australia, the capsules are dispensed under the Therapeutic Goods Administration's Authorized Prescriber Scheme and are reimbursed by payers including the Department of Veterans'</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Optimi+Health+ships+psilocybin+capsules+to+Australia+in+third+export/26704240.html</guid>
   <pubDate>Mon, 29 Jun 2026 11:37:53 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">8BN0</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPTH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPTI</category>
   	  </item>
  <item>
   <title>Optimi Health ships psilocybin capsules to Australia in third export</title>
   <link>http://www.streetinsider.com/Corporate+News/Optimi+Health+ships+psilocybin+capsules+to+Australia+in+third+export/26704240.html</link>
   <description>&lt;p&gt;Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN0) has completed its third commercial shipment of 5mg psilocybin capsules to Australia since launching the product in September 2025, according to a company press release.&lt;/p&gt;&lt;p&gt;The shipment consisted of 1,000 capsules produced at Optimi's GMP-certified facility in Princeton, British Columbia, and exported under authorization from Health Canada. The capsules are prescribed in Australia for treatment-resistant depression, defined as major depression that has not responded to multiple standard antidepressant treatments.&lt;/p&gt;&lt;p&gt;In Australia, the capsules are dispensed under the Therapeutic Goods Administration's Authorized Prescriber Scheme and are reimbursed by payers including the Department of Veterans'</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Optimi+Health+ships+psilocybin+capsules+to+Australia+in+third+export/26704240.html</guid>
   <pubDate>Mon, 29 Jun 2026 11:37:53 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">8BN0</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPTH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPTI</category>
   	  </item>
  <item>
   <title>Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression</title>
   <link>http://www.streetinsider.com/Press+Releases/Optimi+Health+Completes+Psilocybin+Export+to+Australia+for+Patients+With+Treatment-Resistant+Depression/26704125.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p class=&quot;prntac&quot;&gt;&lt;i&gt;Optimi's 5mg psilocybin capsules are prescribed in &lt;location value=&quot;LC/au&quot; idsrc=&quot;xmltag.org&quot; &gt;Australia&lt;/location&gt; for treatment-resistant depression.&lt;br /&gt;&lt;/i&gt;&lt;i&gt;The export marks Optimi's third commercial shipment since launching the 5mg psilocybin capsules in &lt;chron&gt;September 2025&lt;/chron&gt;.&lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/ca.bc.vancvr&quot; idsrc=&quot;xmltag.org&quot; &gt;VANCOUVER, BC&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;June 29, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ - &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4721659-1&amp;amp;h=4275734509&amp;amp;u=https%3A%2F%2Fwww.optimihealth.ca%2F&amp;amp;a=Optimi+Health+Corp.&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;NASDAQ-NMS:OPTH&quot; idsrc=&quot;xmltag.org&quot; &gt;Optimi Health Corp.&lt;/span&gt;&lt;/a&gt; (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN0) (the &quot;&lt;b&gt;Company&lt;/b&gt;&quot; or &quot;&lt;b&gt;Optimi&lt;/b&gt;&quot;), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, today announced the completion of its latest export of 5mg psilocybin finished drug product to &lt;location value=&quot;LC/au&quot; idsrc=&quot;xmltag.org&quot; &gt;Australia&lt;/location&gt;, marking its third commercial shipment since the &lt;chron&gt;September 2025&lt;/chron&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Optimi+Health+Completes+Psilocybin+Export+to+Australia+for+Patients+With+Treatment-Resistant+Depression/26704125.html</guid>
   <pubDate>Mon, 29 Jun 2026 11:13:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">8BN0</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.34929518</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53098441</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPTH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPTI</category>
   	  </item>
  <item>
   <title>Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression</title>
   <link>http://www.streetinsider.com/Press+Releases/Optimi+Health+Completes+Psilocybin+Export+to+Australia+for+Patients+With+Treatment-Resistant+Depression/26704125.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p class=&quot;prntac&quot;&gt;&lt;i&gt;Optimi's 5mg psilocybin capsules are prescribed in &lt;location value=&quot;LC/au&quot; idsrc=&quot;xmltag.org&quot; &gt;Australia&lt;/location&gt; for treatment-resistant depression.&lt;br /&gt;&lt;/i&gt;&lt;i&gt;The export marks Optimi's third commercial shipment since launching the 5mg psilocybin capsules in &lt;chron&gt;September 2025&lt;/chron&gt;.&lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/ca.bc.vancvr&quot; idsrc=&quot;xmltag.org&quot; &gt;VANCOUVER, BC&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;June 29, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ - &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4721659-1&amp;amp;h=4275734509&amp;amp;u=https%3A%2F%2Fwww.optimihealth.ca%2F&amp;amp;a=Optimi+Health+Corp.&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;NASDAQ-NMS:OPTH&quot; idsrc=&quot;xmltag.org&quot; &gt;Optimi Health Corp.&lt;/span&gt;&lt;/a&gt; (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN0) (the &quot;&lt;b&gt;Company&lt;/b&gt;&quot; or &quot;&lt;b&gt;Optimi&lt;/b&gt;&quot;), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, today announced the completion of its latest export of 5mg psilocybin finished drug product to &lt;location value=&quot;LC/au&quot; idsrc=&quot;xmltag.org&quot; &gt;Australia&lt;/location&gt;, marking its third commercial shipment since the &lt;chron&gt;September 2025&lt;/chron&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Optimi+Health+Completes+Psilocybin+Export+to+Australia+for+Patients+With+Treatment-Resistant+Depression/26704125.html</guid>
   <pubDate>Mon, 29 Jun 2026 11:13:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">8BN0</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.34929518</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53098441</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPTH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPTI</category>
   	  </item>
  <item>
   <title>Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression</title>
   <link>http://www.streetinsider.com/Press+Releases/Optimi+Health+Completes+Psilocybin+Export+to+Australia+for+Patients+With+Treatment-Resistant+Depression/26704125.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p class=&quot;prntac&quot;&gt;&lt;i&gt;Optimi's 5mg psilocybin capsules are prescribed in &lt;location value=&quot;LC/au&quot; idsrc=&quot;xmltag.org&quot; &gt;Australia&lt;/location&gt; for treatment-resistant depression.&lt;br /&gt;&lt;/i&gt;&lt;i&gt;The export marks Optimi's third commercial shipment since launching the 5mg psilocybin capsules in &lt;chron&gt;September 2025&lt;/chron&gt;.&lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/ca.bc.vancvr&quot; idsrc=&quot;xmltag.org&quot; &gt;VANCOUVER, BC&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;June 29, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ - &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4721659-1&amp;amp;h=4275734509&amp;amp;u=https%3A%2F%2Fwww.optimihealth.ca%2F&amp;amp;a=Optimi+Health+Corp.&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;NASDAQ-NMS:OPTH&quot; idsrc=&quot;xmltag.org&quot; &gt;Optimi Health Corp.&lt;/span&gt;&lt;/a&gt; (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN0) (the &quot;&lt;b&gt;Company&lt;/b&gt;&quot; or &quot;&lt;b&gt;Optimi&lt;/b&gt;&quot;), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, today announced the completion of its latest export of 5mg psilocybin finished drug product to &lt;location value=&quot;LC/au&quot; idsrc=&quot;xmltag.org&quot; &gt;Australia&lt;/location&gt;, marking its third commercial shipment since the &lt;chron&gt;September 2025&lt;/chron&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Optimi+Health+Completes+Psilocybin+Export+to+Australia+for+Patients+With+Treatment-Resistant+Depression/26704125.html</guid>
   <pubDate>Mon, 29 Jun 2026 11:13:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">8BN0</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.34929518</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53098441</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPTH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPTI</category>
   	  </item>
  <item>
   <title>Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression</title>
   <link>http://www.streetinsider.com/Press+Releases/Optimi+Health+Completes+Psilocybin+Export+to+Australia+for+Patients+With+Treatment-Resistant+Depression/26704125.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p class=&quot;prntac&quot;&gt;&lt;i&gt;Optimi's 5mg psilocybin capsules are prescribed in &lt;location value=&quot;LC/au&quot; idsrc=&quot;xmltag.org&quot; &gt;Australia&lt;/location&gt; for treatment-resistant depression.&lt;br /&gt;&lt;/i&gt;&lt;i&gt;The export marks Optimi's third commercial shipment since launching the 5mg psilocybin capsules in &lt;chron&gt;September 2025&lt;/chron&gt;.&lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/ca.bc.vancvr&quot; idsrc=&quot;xmltag.org&quot; &gt;VANCOUVER, BC&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;June 29, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ - &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4721659-1&amp;amp;h=4275734509&amp;amp;u=https%3A%2F%2Fwww.optimihealth.ca%2F&amp;amp;a=Optimi+Health+Corp.&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;NASDAQ-NMS:OPTH&quot; idsrc=&quot;xmltag.org&quot; &gt;Optimi Health Corp.&lt;/span&gt;&lt;/a&gt; (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN0) (the &quot;&lt;b&gt;Company&lt;/b&gt;&quot; or &quot;&lt;b&gt;Optimi&lt;/b&gt;&quot;), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, today announced the completion of its latest export of 5mg psilocybin finished drug product to &lt;location value=&quot;LC/au&quot; idsrc=&quot;xmltag.org&quot; &gt;Australia&lt;/location&gt;, marking its third commercial shipment since the &lt;chron&gt;September 2025&lt;/chron&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Optimi+Health+Completes+Psilocybin+Export+to+Australia+for+Patients+With+Treatment-Resistant+Depression/26704125.html</guid>
   <pubDate>Mon, 29 Jun 2026 11:13:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">8BN0</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.34929518</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53098441</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPTH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPTI</category>
   	  </item>
  <item>
   <title>Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression</title>
   <link>http://www.streetinsider.com/Press+Releases/Optimi+Health+Completes+Psilocybin+Export+to+Australia+for+Patients+With+Treatment-Resistant+Depression/26704125.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p class=&quot;prntac&quot;&gt;&lt;i&gt;Optimi's 5mg psilocybin capsules are prescribed in &lt;location value=&quot;LC/au&quot; idsrc=&quot;xmltag.org&quot; &gt;Australia&lt;/location&gt; for treatment-resistant depression.&lt;br /&gt;&lt;/i&gt;&lt;i&gt;The export marks Optimi's third commercial shipment since launching the 5mg psilocybin capsules in &lt;chron&gt;September 2025&lt;/chron&gt;.&lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/ca.bc.vancvr&quot; idsrc=&quot;xmltag.org&quot; &gt;VANCOUVER, BC&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;June 29, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ - &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4721659-1&amp;amp;h=4275734509&amp;amp;u=https%3A%2F%2Fwww.optimihealth.ca%2F&amp;amp;a=Optimi+Health+Corp.&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;NASDAQ-NMS:OPTH&quot; idsrc=&quot;xmltag.org&quot; &gt;Optimi Health Corp.&lt;/span&gt;&lt;/a&gt; (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN0) (the &quot;&lt;b&gt;Company&lt;/b&gt;&quot; or &quot;&lt;b&gt;Optimi&lt;/b&gt;&quot;), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, today announced the completion of its latest export of 5mg psilocybin finished drug product to &lt;location value=&quot;LC/au&quot; idsrc=&quot;xmltag.org&quot; &gt;Australia&lt;/location&gt;, marking its third commercial shipment since the &lt;chron&gt;September 2025&lt;/chron&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Optimi+Health+Completes+Psilocybin+Export+to+Australia+for+Patients+With+Treatment-Resistant+Depression/26704125.html</guid>
   <pubDate>Mon, 29 Jun 2026 11:13:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">8BN0</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.34929518</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53098441</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPTH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPTI</category>
   	  </item>
  <item>
   <title>Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression</title>
   <link>http://www.streetinsider.com/Press+Releases/Optimi+Health+Completes+Psilocybin+Export+to+Australia+for+Patients+With+Treatment-Resistant+Depression/26704125.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p class=&quot;prntac&quot;&gt;&lt;i&gt;Optimi's 5mg psilocybin capsules are prescribed in &lt;location value=&quot;LC/au&quot; idsrc=&quot;xmltag.org&quot; &gt;Australia&lt;/location&gt; for treatment-resistant depression.&lt;br /&gt;&lt;/i&gt;&lt;i&gt;The export marks Optimi's third commercial shipment since launching the 5mg psilocybin capsules in &lt;chron&gt;September 2025&lt;/chron&gt;.&lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/ca.bc.vancvr&quot; idsrc=&quot;xmltag.org&quot; &gt;VANCOUVER, BC&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;June 29, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ - &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4721659-1&amp;amp;h=4275734509&amp;amp;u=https%3A%2F%2Fwww.optimihealth.ca%2F&amp;amp;a=Optimi+Health+Corp.&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;NASDAQ-NMS:OPTH&quot; idsrc=&quot;xmltag.org&quot; &gt;Optimi Health Corp.&lt;/span&gt;&lt;/a&gt; (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN0) (the &quot;&lt;b&gt;Company&lt;/b&gt;&quot; or &quot;&lt;b&gt;Optimi&lt;/b&gt;&quot;), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, today announced the completion of its latest export of 5mg psilocybin finished drug product to &lt;location value=&quot;LC/au&quot; idsrc=&quot;xmltag.org&quot; &gt;Australia&lt;/location&gt;, marking its third commercial shipment since the &lt;chron&gt;September 2025&lt;/chron&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Optimi+Health+Completes+Psilocybin+Export+to+Australia+for+Patients+With+Treatment-Resistant+Depression/26704125.html</guid>
   <pubDate>Mon, 29 Jun 2026 11:13:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">8BN0</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.34929518</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53098441</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPTH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPTI</category>
   	  </item>
  <item>
   <title>Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression</title>
   <link>http://www.streetinsider.com/PRNewswire/Optimi+Health+Completes+Psilocybin+Export+to+Australia+for+Patients+With+Treatment-Resistant+Depression/26704125.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p class=&quot;prntac&quot;&gt;&lt;i&gt;Optimi's 5mg psilocybin capsules are prescribed in &lt;location value=&quot;LC/au&quot; idsrc=&quot;xmltag.org&quot; &gt;Australia&lt;/location&gt; for treatment-resistant depression.&lt;br /&gt;&lt;/i&gt;&lt;i&gt;The export marks Optimi's third commercial shipment since launching the 5mg psilocybin capsules in &lt;chron&gt;September 2025&lt;/chron&gt;.&lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/ca.bc.vancvr&quot; idsrc=&quot;xmltag.org&quot; &gt;VANCOUVER, BC&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;June 29, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ - &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4721659-1&amp;amp;h=4275734509&amp;amp;u=https%3A%2F%2Fwww.optimihealth.ca%2F&amp;amp;a=Optimi+Health+Corp.&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;NASDAQ-NMS:OPTH&quot; idsrc=&quot;xmltag.org&quot; &gt;Optimi Health Corp.&lt;/span&gt;&lt;/a&gt; (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN0) (the &quot;&lt;b&gt;Company&lt;/b&gt;&quot; or &quot;&lt;b&gt;Optimi&lt;/b&gt;&quot;), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, today announced the completion of its latest export of 5mg psilocybin finished drug product to &lt;location value=&quot;LC/au&quot; idsrc=&quot;xmltag.org&quot; &gt;Australia&lt;/location&gt;, marking its third commercial shipment since the &lt;chron&gt;September 2025&lt;/chron&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Optimi+Health+Completes+Psilocybin+Export+to+Australia+for+Patients+With+Treatment-Resistant+Depression/26704125.html</guid>
   <pubDate>Mon, 29 Jun 2026 11:13:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">8BN0</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.34929518</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53098441</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPTH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPTI</category>
   	  </item>
  <item>
   <title>Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression</title>
   <link>http://www.streetinsider.com/PRNewswire/Optimi+Health+Completes+Psilocybin+Export+to+Australia+for+Patients+With+Treatment-Resistant+Depression/26704125.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p class=&quot;prntac&quot;&gt;&lt;i&gt;Optimi's 5mg psilocybin capsules are prescribed in &lt;location value=&quot;LC/au&quot; idsrc=&quot;xmltag.org&quot; &gt;Australia&lt;/location&gt; for treatment-resistant depression.&lt;br /&gt;&lt;/i&gt;&lt;i&gt;The export marks Optimi's third commercial shipment since launching the 5mg psilocybin capsules in &lt;chron&gt;September 2025&lt;/chron&gt;.&lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/ca.bc.vancvr&quot; idsrc=&quot;xmltag.org&quot; &gt;VANCOUVER, BC&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;June 29, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ - &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4721659-1&amp;amp;h=4275734509&amp;amp;u=https%3A%2F%2Fwww.optimihealth.ca%2F&amp;amp;a=Optimi+Health+Corp.&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;NASDAQ-NMS:OPTH&quot; idsrc=&quot;xmltag.org&quot; &gt;Optimi Health Corp.&lt;/span&gt;&lt;/a&gt; (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN0) (the &quot;&lt;b&gt;Company&lt;/b&gt;&quot; or &quot;&lt;b&gt;Optimi&lt;/b&gt;&quot;), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, today announced the completion of its latest export of 5mg psilocybin finished drug product to &lt;location value=&quot;LC/au&quot; idsrc=&quot;xmltag.org&quot; &gt;Australia&lt;/location&gt;, marking its third commercial shipment since the &lt;chron&gt;September 2025&lt;/chron&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Optimi+Health+Completes+Psilocybin+Export+to+Australia+for+Patients+With+Treatment-Resistant+Depression/26704125.html</guid>
   <pubDate>Mon, 29 Jun 2026 11:13:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">8BN0</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.34929518</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53098441</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPTH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPTI</category>
   	  </item>
  <item>
   <title>Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression</title>
   <link>http://www.streetinsider.com/PRNewswire/Optimi+Health+Completes+Psilocybin+Export+to+Australia+for+Patients+With+Treatment-Resistant+Depression/26704125.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p class=&quot;prntac&quot;&gt;&lt;i&gt;Optimi's 5mg psilocybin capsules are prescribed in &lt;location value=&quot;LC/au&quot; idsrc=&quot;xmltag.org&quot; &gt;Australia&lt;/location&gt; for treatment-resistant depression.&lt;br /&gt;&lt;/i&gt;&lt;i&gt;The export marks Optimi's third commercial shipment since launching the 5mg psilocybin capsules in &lt;chron&gt;September 2025&lt;/chron&gt;.&lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/ca.bc.vancvr&quot; idsrc=&quot;xmltag.org&quot; &gt;VANCOUVER, BC&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;June 29, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ - &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4721659-1&amp;amp;h=4275734509&amp;amp;u=https%3A%2F%2Fwww.optimihealth.ca%2F&amp;amp;a=Optimi+Health+Corp.&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;NASDAQ-NMS:OPTH&quot; idsrc=&quot;xmltag.org&quot; &gt;Optimi Health Corp.&lt;/span&gt;&lt;/a&gt; (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN0) (the &quot;&lt;b&gt;Company&lt;/b&gt;&quot; or &quot;&lt;b&gt;Optimi&lt;/b&gt;&quot;), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, today announced the completion of its latest export of 5mg psilocybin finished drug product to &lt;location value=&quot;LC/au&quot; idsrc=&quot;xmltag.org&quot; &gt;Australia&lt;/location&gt;, marking its third commercial shipment since the &lt;chron&gt;September 2025&lt;/chron&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Optimi+Health+Completes+Psilocybin+Export+to+Australia+for+Patients+With+Treatment-Resistant+Depression/26704125.html</guid>
   <pubDate>Mon, 29 Jun 2026 11:13:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">8BN0</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.34929518</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53098441</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPTH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPTI</category>
   	  </item>
  <item>
   <title>Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression</title>
   <link>http://www.streetinsider.com/PRNewswire/Optimi+Health+Completes+Psilocybin+Export+to+Australia+for+Patients+With+Treatment-Resistant+Depression/26704125.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p class=&quot;prntac&quot;&gt;&lt;i&gt;Optimi's 5mg psilocybin capsules are prescribed in &lt;location value=&quot;LC/au&quot; idsrc=&quot;xmltag.org&quot; &gt;Australia&lt;/location&gt; for treatment-resistant depression.&lt;br /&gt;&lt;/i&gt;&lt;i&gt;The export marks Optimi's third commercial shipment since launching the 5mg psilocybin capsules in &lt;chron&gt;September 2025&lt;/chron&gt;.&lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/ca.bc.vancvr&quot; idsrc=&quot;xmltag.org&quot; &gt;VANCOUVER, BC&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;June 29, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ - &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4721659-1&amp;amp;h=4275734509&amp;amp;u=https%3A%2F%2Fwww.optimihealth.ca%2F&amp;amp;a=Optimi+Health+Corp.&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;NASDAQ-NMS:OPTH&quot; idsrc=&quot;xmltag.org&quot; &gt;Optimi Health Corp.&lt;/span&gt;&lt;/a&gt; (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN0) (the &quot;&lt;b&gt;Company&lt;/b&gt;&quot; or &quot;&lt;b&gt;Optimi&lt;/b&gt;&quot;), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, today announced the completion of its latest export of 5mg psilocybin finished drug product to &lt;location value=&quot;LC/au&quot; idsrc=&quot;xmltag.org&quot; &gt;Australia&lt;/location&gt;, marking its third commercial shipment since the &lt;chron&gt;September 2025&lt;/chron&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Optimi+Health+Completes+Psilocybin+Export+to+Australia+for+Patients+With+Treatment-Resistant+Depression/26704125.html</guid>
   <pubDate>Mon, 29 Jun 2026 11:13:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">8BN0</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.34929518</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53098441</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPTH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPTI</category>
   	  </item>
  <item>
   <title>Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression</title>
   <link>http://www.streetinsider.com/PRNewswire/Optimi+Health+Completes+Psilocybin+Export+to+Australia+for+Patients+With+Treatment-Resistant+Depression/26704125.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p class=&quot;prntac&quot;&gt;&lt;i&gt;Optimi's 5mg psilocybin capsules are prescribed in &lt;location value=&quot;LC/au&quot; idsrc=&quot;xmltag.org&quot; &gt;Australia&lt;/location&gt; for treatment-resistant depression.&lt;br /&gt;&lt;/i&gt;&lt;i&gt;The export marks Optimi's third commercial shipment since launching the 5mg psilocybin capsules in &lt;chron&gt;September 2025&lt;/chron&gt;.&lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/ca.bc.vancvr&quot; idsrc=&quot;xmltag.org&quot; &gt;VANCOUVER, BC&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;June 29, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ - &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4721659-1&amp;amp;h=4275734509&amp;amp;u=https%3A%2F%2Fwww.optimihealth.ca%2F&amp;amp;a=Optimi+Health+Corp.&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;NASDAQ-NMS:OPTH&quot; idsrc=&quot;xmltag.org&quot; &gt;Optimi Health Corp.&lt;/span&gt;&lt;/a&gt; (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN0) (the &quot;&lt;b&gt;Company&lt;/b&gt;&quot; or &quot;&lt;b&gt;Optimi&lt;/b&gt;&quot;), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, today announced the completion of its latest export of 5mg psilocybin finished drug product to &lt;location value=&quot;LC/au&quot; idsrc=&quot;xmltag.org&quot; &gt;Australia&lt;/location&gt;, marking its third commercial shipment since the &lt;chron&gt;September 2025&lt;/chron&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Optimi+Health+Completes+Psilocybin+Export+to+Australia+for+Patients+With+Treatment-Resistant+Depression/26704125.html</guid>
   <pubDate>Mon, 29 Jun 2026 11:13:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">8BN0</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.34929518</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53098441</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPTH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPTI</category>
   	  </item>
  <item>
   <title>Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression</title>
   <link>http://www.streetinsider.com/PRNewswire/Optimi+Health+Completes+Psilocybin+Export+to+Australia+for+Patients+With+Treatment-Resistant+Depression/26704125.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p class=&quot;prntac&quot;&gt;&lt;i&gt;Optimi's 5mg psilocybin capsules are prescribed in &lt;location value=&quot;LC/au&quot; idsrc=&quot;xmltag.org&quot; &gt;Australia&lt;/location&gt; for treatment-resistant depression.&lt;br /&gt;&lt;/i&gt;&lt;i&gt;The export marks Optimi's third commercial shipment since launching the 5mg psilocybin capsules in &lt;chron&gt;September 2025&lt;/chron&gt;.&lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/ca.bc.vancvr&quot; idsrc=&quot;xmltag.org&quot; &gt;VANCOUVER, BC&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;June 29, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ - &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4721659-1&amp;amp;h=4275734509&amp;amp;u=https%3A%2F%2Fwww.optimihealth.ca%2F&amp;amp;a=Optimi+Health+Corp.&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;NASDAQ-NMS:OPTH&quot; idsrc=&quot;xmltag.org&quot; &gt;Optimi Health Corp.&lt;/span&gt;&lt;/a&gt; (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN0) (the &quot;&lt;b&gt;Company&lt;/b&gt;&quot; or &quot;&lt;b&gt;Optimi&lt;/b&gt;&quot;), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, today announced the completion of its latest export of 5mg psilocybin finished drug product to &lt;location value=&quot;LC/au&quot; idsrc=&quot;xmltag.org&quot; &gt;Australia&lt;/location&gt;, marking its third commercial shipment since the &lt;chron&gt;September 2025&lt;/chron&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Optimi+Health+Completes+Psilocybin+Export+to+Australia+for+Patients+With+Treatment-Resistant+Depression/26704125.html</guid>
   <pubDate>Mon, 29 Jun 2026 11:13:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">8BN0</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.34929518</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53098441</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPTH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OPTI</category>
   	  </item>
 </channel>
</rss>
